Literature DB >> 6269249

Superoxide, xanthine oxidase and platelet reactions: further studies on mechanisms by which oxidants influence platelets.

P H Levine, D G Sladdin, N I Krinsky.   

Abstract

In the course of studying the effects on platelets of the oxidant species superoxide (O2.-), O2.- was generated by the interaction of xanthine oxidase plus xanthine. Surprisingly, gel-filtered platelets, when exposed to xanthine oxidase in the absence of xanthine substrate, were found to generate superoxide (O2.-), as determined by the reduction of added cytochrome c and by the inhibition of this reduction in the presence of superoxide dismutase. In addition to generating O2.-, the xanthine oxidase-treated platelets display both aggregation and evidence of the release reaction. This xanthine oxidase induced aggregation is not inhibited by the addition of either superoxide dismutase or cytochrome c, suggesting that it is due to either a further metabolite of O2.0, or that O2.- itself exerts no important direct effect on platelet function under these experimental conditions. The ability of C2.- to modulate platelet reactions in vivo or in vitro remains in doubt, and xanthine oxidase is an unsuitable source of O2.- in platelet studies because of its own effects on platelets.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269249

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  Cellular effects of proteinase activity in commercial xanthine oxidase.

Authors:  A Ager; J L Gordon
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

2.  Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics.

Authors:  L M Yerges-Armstrong; S Ellero-Simatos; A Georgiades; H Zhu; J P Lewis; R B Horenstein; A L Beitelshees; A Dane; T Reijmers; T Hankemeier; O Fiehn; A R Shuldiner; R Kaddurah-Daouk
Journal:  Clin Pharmacol Ther       Date:  2013-06-11       Impact factor: 6.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.